Guided Therapeutics (GTHP) Inventory (2011 - 2025)

Guided Therapeutics has disclosed Inventory across 15 years of filings, most recently posting $448000.0 for Q4 2025.

• Inventory for Q4 2025 came in at $448000.0, down 29.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $448000.0 (down 29.23% YoY), and the FY2025 annual result was $448000.0, down 29.23% from the prior year.
• Inventory came in at $448000.0 for Q4 2025 at Guided Therapeutics, down from $583000.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $648000.0 in Q3 2023 to a low of $448000.0 in Q4 2025.
• The 5-year median for Inventory is $595500.0 (2022), against an average of $595550.0.
• Across the five-year window, Inventory soared 1137.25% in 2021 and slipped 29.23% in 2025, its largest moves.
• Guided Therapeutics' Inventory stood at $571000.0 in 2021, then dropped by 4.03% to $548000.0 in 2022, then advanced by 15.33% to $632000.0 in 2023, then increased by 0.16% to $633000.0 in 2024, then retreated by 29.23% to $448000.0 in 2025.
• The last three Inventory figures came in at $448000.0 (Q4 2025), $583000.0 (Q3 2025), and $595000.0 (Q2 2025), per Business Quant data.